MSCI (MSCI) Appoints Michelle Seitz to its Board

MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced that Michelle Seitz, the former Chair and CEO of Russell Investments, has been appointed to serve as an independent director on MSCI’s Board of Directors (the “Board”), effective August 5, 2024. Ms. Seitz will serve as a member of the Audit and Risk Committee of the Board. Ms. Seitz’s appointment comes after an extensive search initiated last year.

“Michelle has deep experience in the investment industry, having spent more than three decades in asset management and private wealth, both as a CEO and as an investor,” said Henry A. Fernandez, Chairman and Chief Executive Officer of MSCI. “She has driven transformational growth while fostering an award-winning, client-centric culture. Her leadership experience, knowledge of the investment industry and ability to lead and grow large global organizations will all contribute meaningfully to the MSCI Board,” added Mr. Fernandez.

“MSCI is at the forefront of supporting clients as they navigate a complex and transforming investment landscape, and I am thrilled to be joining in their mission to bring greater transparency to financial markets,” said Ms. Seitz. “The Board of MSCI is comprised of diverse and talented individuals, and I look forward to working closely with my fellow Board members and management to continue supporting our clients, shareholders, employees and the broader investment community.”

Michelle Seitz, a seasoned business executive and investor, is the Founder and CEO of MeydenVest Partners, a private investment and strategic advisory firm launched in 2022. Prior to this, she served as the Chair and CEO of Russell Investments, one of the world’s largest asset management firms, where she enhanced profitability and scalability. Before Russell Investments, Ms. Seitz held various leadership roles at William Blair, including CEO of William Blair Investment Management, where she led the firm to achieve fivefold growth, establishing it as an internationally recognized global asset and wealth management firm. Currently, she also serves as a director on the board of SANA Biotechnology. Ms. Seitz is a graduate of the Kelley School of Business at Indiana University, and is a Chartered Financial Analyst (CFA). She has been recognized as one of the most influential women in U.S. finance.

You May Also Be Interested In

• SpaceX (SPCX) Indicated to Open at $174
• Omeros (OMER) Halted on Circuit Volatility, Down 22%
• BofA Securities Starts Dollarama Inc. (DOL:CN) (DLMAF) at Buy